October 2013 FDA Recall Alprazolam by Actavis Elizabeth Llc
D-018-2014 - Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets

This Class II drug recall was voluntarily initiated by Actavis Elizabeth Llc on October 9, 2013 for the product Alprazolam. The FDA reported the reason for recall as failed tablet/capsule specifications; partial tablet erosion resulting in tablet weights below specification in some tablets. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-018-2014

Reason for Recall
Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets
Initiated
10-09-2013
Reported
12-04-2013
Quantity
756 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Actavis Elizabeth LLC
Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., Elizabeth, NJ, NDC 0228-4025-11

Batch or Lot Expiration Information

Lot# 59380831, Exp. May 2014